Consensus Lemonade, Inc.

Stocks

LMND

US52567D1072

Property & Casualty Insurance

Real-time Estimate Cboe BZX Other stock markets 20:09:04 28/07/2026 +04			5-day change	1st Jan Change
63.16 ^USD	+1.89%		-8.87%	-12.15%

07-14	Lemonade Expands Renters Insurance to Maine	CI
07-09	Lemonade Insider Sold Shares Worth $5,780,140, According to a Recent SEC Filing	MT

Evolution of the Average Target: Lemonade, Inc.

Evolution of the Target Price: Lemonade, Inc.

Changes in Analyst Recommendations: Lemonade, Inc.

e258a781ae696.7D3TV9LOr1uIeR5gRIPrGjBVV71INxStjFZm6OB12ug.oX-2IrCF-C_YE1M4PuyFL18RII8leX7G2REMiq0jrYKUbIEDupj-F_A8Ww~00e6b717ab93ec8e2bd97dd77c5e781c

Analysts' recommendations: Lemonade, Inc.

07-08	Lemonade's Share Rally Leaves Limited Upside Without New Catalysts, Morgan Stanley Says	MT
07-08	Morgan Stanley Downgrades Lemonade to Equalweight From Overweight, Maintains $75 Price Target	MT
06-08	TD Cowen Raises Lemonade Price Target to $55 From $33, Hold Rating Kept	MT
03-17	Lemonade Shares Rise After Morgan Stanley Upgrade	MT
03-17	Morgan Stanley Upgrades Lemonade to Overweight From Equalweight, Adjusts PTto $85 From $80	MT
01-06	Truist Initiates Lemonade at Buy With $98 Price Target	MT
12-17	Lemonade Shares Rise After Morgan Stanley Upgrade	MT
12-16	Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Adjusts Price Target to $85 From $53	MT
13/08/25	Cantor Fitzgerald Initiates Coverage on Lemonade With Overweight Rating, $60 Price Target	MT
08/04/25	Lemonade Faces Growth Hurdles Amid Tariffs, Competition, Market Uncertainty, Morgan Stanley Says	MT
08/04/25	Morgan Stanley Downgrades Lemonade to Underweight From Equalweight, Adjusts PT to $24 From $35	MT
20/11/24	Morgan Stanley Upgrades Lemonade to Equalweight From Underweight, Raises Price Target to $42 From $23	MT
07/11/24	Keefe Bruyette & Woods Downgrades Lemonade to Underperform, Price Target is $21	MT
31/10/24	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating	MT
07/05/24	Jefferies Adjusts Price Target on Lemonade to $16 From $14, Maintains Underperform Rating	MT
01/05/24	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Keeps Underweight Rating	MT
07/11/23	Morgan Stanley Adjusts Price Target on Lemonade to $12 From $11, Maintains Underweight Rating	MT
11/10/23	Morgan Stanley Adjusts Price Target on Lemonade to $10 From $15, Maintains Underweight Rating	MT
28/09/23	BMO Capital Adjusts Price Target on Lemonade to $9 From $8, Maintains Underperform Rating	MT
04/08/23	Piper Sandler Adjusts Price Target on Lemonade to $17 From $18, Maintains Neutral Rating	MT
03/08/23	Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Maintains Underweight Rating	MT
20/06/23	Morgan Stanley Initiates Lemonade at Underweight With $14 Price Target, Says Stock Doesn't Reflect Long Path to Profitability	MT
09/05/23	Barclays Adjusts Price Target on Lemonade to $17 From $16, Keeps Equalweight Rating	MT
04/05/23	BofA Securities Adjusts Lemonade's Price Target to $12 From $14, Keeps Underperform Rating	MT
10/04/23	Jefferies Cuts Price Target on Lemonade to $11.50 From $13, Maintains Underperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LEMONADE, INC.					+3.6%
	TOKIO MARINE HOLDINGS, INC.					+4.34%
	THE TRAVELERS COMPANIES, INC.					-8.33%
	THE ALLSTATE CORPORATION					-2.52%
	MS&AD INSURANCE GROUP HOLDINGS, INC.					-3.56%
	AMERICAN INTERNATIONAL GROUP, INC.					+11.86%
	SOMPO HOLDINGS, INC.					-9.47%
	FAIRFAX FINANCIAL HOLDINGS LIMITED					+13.46%
	INTACT FINANCIAL CORPORATION					+9.32%
	ARCH CAPITAL GROUP LTD.					+6.47%
	Average					+2.52%
	Weighted average by Cap.					+1.33%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

61.99USD

Average target price

64.22USD

Spread / Average Target

+3.60%

High Price Target

92.00USD

Spread / Highest target

+48.41%

Low Price Target

40.00USD

Spread / Lowest Target

-35.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
TD Cowen
Truist Securities
Cantor Fitzgerald
Keefe Bruyette & Woods
Jefferies & Co.
BMO Capital
Piper Sandler
Barclays
BofA Securities
Keefe, Bruyette & Woods
Oppenheimer
JMP Securities
Autonomous Research
Wolfe Research